subject
cf
recruit
inpati
outpati
servic
royal
children
hospit
princ
charl
hospit
brisban
australia
inclus
criteria
age
year
confirm
diagnosi
cf
cultur
p
aeruginosa
b
cepacia
complex
sputum
least
one
occas
within
previou
month
exclus
criteria
includ
known
pregnanc
pneumothorax
within
previou
month
histori
cough
syncop
vomit
associ
cough
first
subject
experienc
recurr
mild
haemoptysi
cough
studi
exclud
haemoptysi
previou
day
subject
exclud
hyperton
salin
inhal
histori
intoler
hyperton
salin
presenc
asthma
symptom
forc
expiratori
volum
predict
previou
trial
hyperton
salin
subject
ask
withhold
nebulis
therapi
h
prior
test
equip
use
modif
develop
brief
subject
cough
mouthpiec
connect
affer
tube
chamber
whereupon
vacuum
pump
draw
exhal
air
gener
respiratori
particl
one
two
anderson
sixstag
impactor
stage
hole
decreas
diamet
appropriatelys
aerosolis
particl
penetr
deposit
agar
plate
settl
plate
agar
place
insid
chamber
captur
larger
droplet
larger
particl
droplet
would
expect
deposit
affer
limb
tube
settl
plate
wall
chamber
addit
detail
provid
onlin
data
supplement
andersen
impactor
load
agar
plate
room
temperatur
tube
vacuum
pump
attach
port
first
sixstag
impactor
cass
first
session
cough
tube
move
second
sampler
unus
port
occlud
plastic
tape
subject
instruct
cough
cass
frequent
strongli
comfort
min
onset
cough
timer
set
min
control
power
vacuum
pump
start
cough
strength
assess
strong
moder
weak
cough
frequenc
assess
quantit
hyperton
salin
could
toler
first
sampl
done
voluntari
cough
second
sampl
collect
inhal
ml
salin
deliv
handheld
ultrason
nebulis
microneb
allersearch
distribut
becton
dickinson
north
ryde
australia
subject
pretreat
albuterol
meter
dose
inhal
per
puff
puff
via
spacer
volumat
allen
hanburi
uk
hyperton
salin
consid
safe
sampl
done
subject
use
tidal
breath
min
sputum
sampl
collect
produc
forc
expiratori
volum
forc
vital
capac
fvc
obtain
accord
standard
guidelin
prior
cough
respiratori
muscl
strength
assess
use
maximum
inspiratori
pressur
mip
maximum
expiratori
pressur
mep
morgan
pmax
paediatr
centr
use
micro
medic
respiratori
pressur
meter
micro
medic
rochest
uk
adult
centr
age
gender
presenc
current
exacerb
diseas
height
weight
bodi
mass
index
record
use
centrifug
air
sampler
two
sampl
obtain
cough
aerosol
studi
one
subject
perform
spirometri
one
cough
aerosol
studi
indoor
air
temperatur
rel
humid
measur
thermohygromet
rotron
hygropalm
rotron
instrument
corp
huntington
new
york
usa
begin
studi
effect
air
exchang
rate
consult
room
use
cass
test
pulmonari
function
laboratori
adult
centr
determin
use
carbon
dioxid
tracer
ga
detail
provid
onlin
supplement
cultur
perform
use
chocol
bacitracin
agar
aerob
condit
h
h
incub
coloni
form
unit
cfu
count
perform
plate
includ
individu
coloni
p
aeruginosa
morphotyp
combin
total
cfu
count
p
aeruginosa
gramneg
bacteria
follow
presumpt
screen
characterist
coloni
appear
presenc
oxidas
growth
ident
p
aeruginosa
isol
confirm
speciesspecif
oprl
gene
nonfer
gramneg
bacteria
detect
throughout
studi
identifi
use
combin
api
biomerieux
amplifi
rdna
restrict
analysi
ardra
recabas
pcr
andersen
sampler
stage
contain
hole
cfu
regard
result
infecti
particl
within
specif
size
rang
impact
agar
coloni
count
exceed
interpret
two
way
accept
positivehol
correct
model
take
account
probabl
multipl
hit
hole
conserv
model
maximum
count
total
sum
p
aeruginosa
b
cepacia
complex
coloni
count
total
count
andersen
stage
min
voluntari
cough
min
hyperton
salin
studi
tidal
breath
calcul
sum
coloni
stage
term
small
aerosol
fraction
standard
quantit
cultur
method
air
sampl
affer
limb
cultur
gramneg
nonfer
bacteria
assess
isol
identifi
molecular
strain
type
p
aeruginosa
isol
detail
provid
onlin
data
supplement
count
individu
compon
total
andersen
stage
total
andersen
stage
small
fraction
logarithm
transform
analysi
correct
skew
mean
confid
limit
ci
back
transform
log
linear
scale
present
pair
differ
count
voluntari
cough
hyperton
tidal
breath
studi
analys
pair
test
mean
differ
also
back
transform
log
linear
scale
calcul
ratio
count
voluntari
cough
hyperton
tidal
breath
studi
correl
coeffici
estim
logarithm
transform
total
count
clinic
demograph
factor
avail
subject
fisher
exact
test
use
associ
posit
air
sampl
high
total
count
report
p
valu
twosid
linear
regress
use
estim
slope
relationship
total
count
analys
perform
spss
softwar
version
twentyeight
subject
children
adult
consecut
recruit
complet
min
voluntari
cough
twenti
subject
administ
nebulis
hyperton
salin
seven
subject
measur
tidal
breath
one
subject
perform
voluntari
cough
thirteen
subject
studi
pulmonari
exacerb
tabl
month
studi
subject
sputum
cultur
posit
p
aeruginosa
one
subject
cultur
b
cenocepacia
tabl
patient
p
aeruginosa
infect
adult
n
children
chronic
infect
base
leed
one
child
recent
clear
new
infect
p
aeruginosa
follow
erad
cours
antibiot
therapi
cultur
normal
respiratori
flora
sputum
sampl
collect
day
test
patient
b
cenocepacia
chronic
infect
base
leed
criteria
tabl
studi
day
subject
provid
expector
sputum
sampl
one
subject
grew
b
cenocepacia
expect
p
aeruginosa
cultur
six
subject
staphylococcu
aureu
cultur
two
methicillinresist
aureu
cultur
organ
cultur
sputum
includ
streptococci
aspergillu
speci
yeast
molecular
strain
type
demonstr
common
clone
correspond
previous
describ
australian
epidem
strain
subject
adult
children
uniqu
strain
adult
child
tabl
subject
cough
aerosol
grew
p
aeruginosa
one
subject
cultur
p
aeruginosa
cough
aerosol
hyperton
salin
studi
voluntari
cough
one
subject
cultur
b
cenocepacia
cough
aerosol
two
subject
gramneg
bacteria
cultur
cough
aerosol
five
subject
cough
aerosol
p
aeruginosa
addit
gramneg
bacteria
cocultur
stenotrophomona
maltophilia
four
achromobact
xylosoxidan
one
tabl
two
subject
cocultur
maltophilia
produc
sputum
sputum
cultur
neg
maltophilia
two
three
four
subject
cultur
maltophilia
intermitt
sputum
time
subject
xylosoxidan
cough
aerosol
cultur
cultur
organ
sputum
sampl
occas
although
subject
known
chronic
infect
organ
cultur
repeatedli
previou
sputum
sampl
correct
total
count
cfu
obtain
gener
aerosol
vari
wide
among
subject
log
normal
distribut
voluntari
cough
rang
cfu
fig
subject
one
cultur
p
aeruginosa
sputum
also
cultur
p
aeruginosa
ident
genotyp
cass
cough
aerosol
total
count
sputum
correl
total
correct
count
voluntari
cough
aerosol
r
p
three
seven
subject
tidal
breath
studi
posit
cass
aerosol
cultur
p
aeruginosa
cultur
low
number
total
aerosol
count
tidal
breath
cfu
chamber
settl
plate
affer
limb
equip
chang
two
compon
studi
individu
subject
quantit
cultur
reflect
larg
droplet
deposit
compon
studi
combin
mean
total
count
settl
plate
cfu
ci
mean
total
count
affer
limb
cfuml
wash
fluid
ci
mean
se
air
exchang
rate
rang
exchang
per
hour
test
room
total
air
sampl
collect
test
sixteen
sampl
cultur
uniqu
strain
p
aeruginosa
test
patient
uniqu
strain
isol
match
sputum
cass
isol
five
air
sampl
cultur
strain
test
four
subject
strain
p
aeruginosa
four
subject
sputum
cough
aerosol
air
sampl
cultiv
strain
three
posit
air
sampl
collect
pulmonari
function
test
two
background
test
cass
studi
room
posit
air
sampl
associ
high
concentr
cough
aerosol
subject
consid
four
five
subject
total
cough
aerosol
count
cfu
posit
air
sampl
subject
lower
total
cfu
count
posit
air
sampl
p
temperatur
humid
vari
significantli
studi
site
studi
day
site
data
shown
infect
particl
size
distribut
cough
aerosol
p
aeruginosa
b
cenocepacia
voluntari
cough
shown
fig
use
correct
total
count
particl
ci
contain
cultur
aerosol
isol
voluntari
cough
andersen
stage
andersen
sampler
small
aerosol
fraction
conserv
model
gave
similar
result
ci
small
aerosol
fraction
mean
total
correct
count
much
lower
tidal
breath
ci
voluntari
cough
ci
p
hyperton
salin
ci
signific
differ
total
correct
count
voluntari
cough
hyperton
salin
p
pattern
differ
unaffect
use
conserv
model
data
shown
correl
total
correct
count
voluntari
cough
aerosol
r
p
fig
also
correct
small
aerosol
fraction
r
p
similarli
correl
conserv
total
count
r
p
conserv
small
aerosol
fraction
r
p
voluntari
cough
signific
associ
cough
aerosol
cfu
count
clinic
factor
includ
gender
age
test
paediatr
adult
centr
current
exacerb
statu
fvc
mip
mep
percentag
predict
presenc
clonal
p
aeruginosa
qualiti
actual
number
cough
count
data
shown
trend
associ
peak
expiratori
flow
r
p
bodi
mass
index
r
p
total
correct
count
voluntari
cough
first
studi
report
magnitud
variabl
particl
size
distribut
cultur
aerosol
gramneg
bacteria
produc
cough
patient
cf
although
evid
cultur
gramneg
bacteria
larg
droplet
within
affer
tube
settl
plate
cough
chamber
larg
proport
cultur
particl
found
size
rang
like
deposit
lower
respiratori
tract
genet
indistinguish
bacteria
identifi
expector
sputum
coughgener
aerosol
four
experi
organ
also
isol
ambient
room
air
support
assert
sourc
bacteria
patient
rather
hospit
nearbi
environ
aerosolis
respiratori
tract
particl
cough
sneez
even
tidal
breath
well
recognis
phenomenon
associ
spread
mani
infect
includ
measl
influenza
major
respiratori
pathogen
thought
spread
larg
droplet
settl
within
approxim
rang
individu
provid
low
risk
airborn
infect
infect
control
practic
cf
centr
reflect
recent
publish
infect
control
guidelin
suggest
patient
maintain
distanc
least
reduc
risk
risk
acquisit
infect
respiratori
aerosol
complex
probabl
relat
pathogen
type
concentr
organ
aerosol
suscept
expos
individu
environ
air
movement
rel
humid
temperatur
etc
limit
studi
examin
particl
size
distribut
respiratori
aerosol
report
larg
droplet
format
predominantli
particl
diamet
recent
papineni
rosenth
report
particl
cough
produc
aerosol
particl
breath
first
publish
studi
use
cass
examin
patient
tuberculosi
like
studi
found
respiratori
particl
studi
show
patient
cf
produc
cultur
aerosol
wide
rang
particl
size
includ
respiratori
droplet
infecti
droplet
nuclei
shown
predominantli
clonal
p
aeruginosa
small
number
patient
nonfer
gramneg
organ
includ
b
cenocepacia
know
ideal
site
deposit
respiratori
tract
p
aeruginosa
establish
infect
patient
cf
either
larg
small
droplet
may
import
pathogenesi
rel
recent
crossinfect
p
aeruginosa
believ
uncommon
limit
sibl
cf
cohort
attend
residenti
cf
identif
genet
relat
p
aeruginosa
strain
mani
cf
centr
uk
europ
australia
suggest
crossinfect
clonal
strain
p
aeruginosa
contamin
air
close
patient
infect
physiotherapi
lung
function
test
result
provid
evid
crossinfect
may
result
direct
inhal
aerosolis
bacteria
studi
demonstr
wide
vari
bacteri
count
cough
aerosol
log
normal
distribut
distribut
consist
descript
highli
infecti
patient
dissemin
eg
tuberculosi
superspread
eg
sever
acut
respiratori
syndrom
factor
influenc
extent
isol
gramneg
bacteria
cough
aerosol
like
complex
includ
host
factor
bacteri
factor
enhanc
surviv
air
data
show
concentr
bacteria
sputum
forc
expiratori
flow
rate
relat
cough
aerosol
concentr
trend
associ
higher
peak
flow
higher
bodi
mass
index
data
suggest
patient
milder
lung
diseas
perhap
result
stronger
cough
may
increas
risk
produc
infecti
aerosol
warrant
investig
improv
clinic
outcom
patient
cf
may
potenti
increas
risk
spread
clonal
strain
p
aeruginosa
gramneg
bacteria
air
sampl
cultur
p
aeruginosa
match
clinic
sampl
sputum
cass
sampl
clonal
strain
given
patient
posit
air
sampl
also
high
total
aerosol
count
unabl
determin
densiti
infect
whether
addit
natur
specif
posit
air
sampl
sourc
p
aeruginosa
air
isol
match
clinic
sampl
unknown
environment
sampl
surfac
undertaken
possibl
environment
sourc
sink
may
involv
hand
wash
occur
test
measur
air
exchang
rate
studi
room
provid
import
perspect
air
sampl
perform
min
occas
period
complet
air
exchang
occur
higher
rate
densiti
posit
air
sampl
may
anticip
less
well
ventil
room
nebulis
hyperton
salin
recognis
improv
mucociliari
sought
determin
hyperton
salineinduc
cough
enhanc
product
bacteri
aerosol
found
similar
result
seen
voluntari
cough
much
greater
obtain
tidal
breath
treatment
physiotherapi
mucolyt
agent
even
nebulis
antibiot
induc
cough
like
result
similar
coughinduc
aerosol
voluntari
cough
although
seen
three
seven
patient
test
tidal
breath
presenc
p
aeruginosa
cough
aerosol
small
aerosol
fraction
two
patient
warrant
studi
reassess
infect
control
recommend
incorpor
role
airborn
transmiss
may
appli
cough
patient
signific
aerosolposit
sputumneg
result
isol
low
number
maltophila
n
xyloxidan
n
uncertain
possibl
separ
respiratori
particl
size
negat
obscur
individu
coloni
morphotyp
flora
may
occur
direct
sputum
cultur
sever
limit
studi
first
studi
power
examin
effect
mani
clinic
variabl
exacerb
strain
p
aeruginosa
product
cough
aerosol
particular
patient
uniqu
strain
p
aeruginosa
none
produc
high
concentr
cough
aerosol
associ
specif
strain
obtain
posit
air
sampl
could
therefor
determin
second
media
andersen
plate
select
gramneg
organ
thu
possibl
generalis
result
patient
cf
infect
gramposit
bacteria
mycobacteria
fungi
third
perform
reproduc
effici
studi
cass
fourth
studi
tidal
breath
select
group
patient
undertak
hyperton
salineinduc
cough
studi
work
requir
evalu
extent
tidal
breath
associ
gener
potenti
infect
particl
final
studi
provid
evid
patient
cf
gramneg
infect
produc
potenti
infecti
cough
aerosol
draw
conclus
transmiss
suscept
individu
recent
studi
examin
surviv
p
aeruginosa
vitro
found
bacteri
surviv
least
limit
time
period
favour
lower
temperatur
mucoid
provid
evid
airborn
transmiss
plausibl
transmiss
rout
yet
prove
beyond
doubt
conclus
studi
show
patient
cf
infect
p
aeruginosa
produc
respir
infecti
cough
aerosol
wide
rang
concentr
log
normal
distribut
also
detect
nonfer
gramneg
bacteria
includ
b
cenocepacia
small
aerosol
fraction
suggest
airborn
transmiss
organ
biolog
plausibl
studi
potenti
airborn
transmiss
bacteri
pathogen
patient
cf
warrant
provid
scientif
basi
infect
control
recommend
prevent
spread
multidrugresist
clonal
strain
p
aeruginosa
gramneg
bacteria
patient
popul
